STORY OF A LEUKEMIA FIGHTER
Nicole L. Gularte, MBA
HOPE is what I felt when I chose to take the alternative to standard treatment for my relapsed/refractory Acute Lymphoblastic Leukemia. In April 2014, I was devastated after Stanford doctors delivered news of my cancer relapse. The thought of going through another three years of torment, had me running from the hospital.
I was given a chance to participate in a new clinical trial where a protein designed new type of treatment in Immunotherapy – a new immunotherapy, called Inotuzumab. This particular drug uses antibodies that target and kill specific cancer cells. I was given the drug in the hospital where doctors monitored me for several weeks. My cancer was gone and I was able to return home where I would wait for a donor match for a stem cell or bone marrow transplant.
Inotuzumab was initially designed for blood…
View original post 970 more words